Responsible AI in Life Sciences: What Leaders Say About Scaling Agentic AI

Hear industry leaders on scaling agentic AI responsibly in Life Sciences and discover the RAIL Score framework.

Register Free: https://www.pharmexec.com/pe_w/Scaling-Agentic-AI

Event Overview:

As agentic AI moves from experimentation to execution, Life Sciences leaders face a critical challenge: how to scale AI while maintaining trust, oversight, and accountability.

Drawing on eight global roundtables and a survey of senior pharma, biotech, and medical device leaders, the Responsible AI in Life Sciences (RAIL) research reveals where AI adoption is outpacing governance and what organizations need to build trust. The session introduces the RAIL Score, a practical framework for evaluating agentic AI across six critical components of responsible AI. Attendees will gain actionable insights and tools to move beyond vendor claims toward measurable standards for responsible AI adoption.

Key Learning Objectives

• Evaluate the risks and returns of scaling agentic AI
• Apply the RAIL Score to assess responsible AI adoption
• Identify where AI adoption is outpacing governance and oversight

Who Should Attend

• Life Sciences leaders responsible for AI strategy, digital transformation, and emerging technology adoption
• Commercialization leaders evaluating where and how to deploy AI across commercial functions
• Medical Affairs leaders evaluating where and how to deploy AI across medical functions

Speakers

Lori Tierney
Chief Commercial Officer
CooperSurgical

Lori Tierney is a seasoned Life Sciences executive with over 20 years of experience bringing innovative therapies to market. Currently, Lori serves as the Chief Commercial Officer at CooperSurgical. Previously, Lori served as President of Johnson & Johnson Vision and held senior global and regional leadership roles across J&J MedTech and Mentor Aesthetics Specialty Surgery. Her career also includes commercial leadership positions at AstraZeneca, Endo Pharmaceuticals, and Centocor, where she led large, global teams and commercial operations supporting more than 10,000 customer-facing professionals, with a strong focus on customer-centric innovation.

Lisa DeMarco
General Counsel & Chief Business Officer
Arctic Therapeutics

Lisa DeMarco is President of LAD Legal Consulting LLC and currently serves as General Counsel and Chief Business Officer of Arctic Therapeutics, a clinical-stage biotech company based in Iceland and the US. She spent over 28 years at GlaxoSmithKline, where she was Vice President and Associate General Counsel, supporting global business development, corporate development, pharmaceutical operations, and consumer healthcare. During her tenure, Lisa also led securities disclosure and reporting, served on the company's Disclosure Committee, and held multiple board and leadership roles across GSK's legal, R&D, and biomedical research organizations.

Parth Khanna
CEO and Co-founder
ACTO

With over 12 years of experience in artificial intelligence and 10 granted U.S. patents in AI, Parth Khanna is a recognized innovator in applying AI and mobile technologies to transform how pharma companies drive field performance and engage healthcare professionals. His deep cross-disciplinary background—spanning Life Sciences, law, and venture-backed tech—has positioned him at the forefront of digital transformation in the pharmaceutical industry.

Alison Muller
Chief Marketing Officer
ACTO

Alison Muller is a global marketing executive with over 30 years of experience in b2b software marketing, from multi-billion-dollar software companies to Series A, B & C tech start-ups. Currently, Alison is the Chief Marketing Officer at ACTO. Previously, Alison served as the Global Head of Health Sciences Marketing at Oracle, where she led the global marketing team and strategy targeting the Life Sciences industry in North America, Europe, Asia Pacific, and Japan. Prior to Oracle, Alison served as Chief Marketing Officer for three different B2B tech startups, which resulted in strategic acquisitions. Before that, Alison served as Vice President of Product Marketing at Intralinks, a global B2B tech company, where she launched a new market that contributed to the company's successful IPO in 2010.

Register Free: https://www.pharmexec.com/pe_w/Scaling-Agentic-AI